Phenotypic profile of alternative activation marker CD163 is different in Alzheimer's and Parkinson's disease
Related Experiment Video
Updated: May 3, 2026

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
Published on: July 7, 2023
Peixuan Pey1, Ronald K B Pearce, Michail E Kalaitzakis
1Neuropathology Unit, Division of Brain Sciences, Department of Medicine, Imperial College London, Charing Cross Campus, St Dunstan's Road, London, UK. peixuan.pey05@imperial.ac.uk.
Background:
Microglial activation is a pathological feature common to both Alzheimer's and Parkinson's diseases (AD and PD). The classical activation involves release of pro-inflammatory cytokines and reactive oxygen species. This is necessary for maintenance of tissue homeostasis and host defense, but can cause bystander damage when the activation is sustained and uncontrolled. In recent years the heterogeneous nature of microglial activation states in neurodegenerative diseases has become clear and the focus has shifted to alternative activation states that promote tissue maintenance and repair. We studied the distribution of CD163, a membrane-bound scavenger receptor found on perivascular macrophages. CD163 has an immunoregulatory function, and has been found in the parenchyma in other inflammatory diseases e.g. HIV-encephalitis and multiple sclerosis. In this study, we used immunohistochemistry to compare CD163 immunoreactivity in 31 AD cases, 27 PD cases, and 16 control cases. Associations of microglia with pathological hallmarks of AD and PD were investigated using double immunofluorescence.
Results:
Parenchymal microglia were found to be immunoreactive for CD163 in all of the AD cases, and to a lesser extent in PD cases. There was prominent staining of CD163 immunoreactive microglia in the frontal and occipital cortices of AD cases, and in the brainstem of PD cases. Many of them were associated with Aß plaques in both diseases, and double staining with CD68 demonstrates their phagocytic capability. Leakage of fibrinogen was observed around compromised blood vessels, raising the possibility these microglia might have originated from the periphery.
Conclusions:
Increase in microglia's CD163 immunoreactivity was more significant in AD than PD, and association of CD163 immunoreactive microglia with Aβ plaques indicate microglia's attraction towards extracellular protein pathology, i.e. extracellular aggregates of Aβ as compared to intracellular Lewy Bodies in PD. Double staining with CD163 and CD68 might point towards their natural inclination to phagocytose plaques. Fibrinogen leakage and compromise of the blood brain barrier raise the possibility that these are not resident microglia, but systemic macrophages infiltrating the brain.
Insights
Microglia show increased CD163 expression in Alzheimer's and Parkinson's diseases, particularly around amyloid plaques in AD. This suggests a potential peripheral origin for some activated microglia in neurodegeneration.
Area of Science:
- Neuroscience
- Immunology
- Pathology
Background:
- Microglial activation is a common feature in Alzheimer's (AD) and Parkinson's diseases (PD).
- Focus is shifting towards alternative microglial activation states that promote tissue repair.
- CD163, a scavenger receptor with immunoregulatory function, is studied in this context.
Purpose of the Study:
- To investigate the distribution and association of CD163 immunoreactivity in microglia in AD and PD.
- To compare CD163 expression patterns between AD, PD, and control cases.
- To explore the potential origin and function of CD163-positive microglia.
Main Methods:
- Immunohistochemistry was used to assess CD163 immunoreactivity.
- 31 AD cases, 27 PD cases, and 16 control cases were analyzed.
- Double immunofluorescence was employed to examine associations with pathological hallmarks and phagocytic markers (CD68).
Main Results:
- CD163 immunoreactivity was present in parenchymal microglia in all AD cases and to a lesser extent in PD cases.
- Prominent CD163 staining was observed in AD cortices and PD brainstems.
- CD163-positive microglia were associated with Aβ plaques and showed phagocytic capability (CD68+), with evidence of fibrinogen leakage suggesting potential peripheral origin.
Conclusions:
- Microglial CD163 immunoreactivity is significantly increased in AD compared to PD.
- CD163-positive microglia are attracted to extracellular pathology like Aβ plaques.
- Fibrinogen leakage suggests that some CD163-positive microglia may be infiltrating macrophages due to blood-brain barrier compromise.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer Disease ll: Pathophysiology
Parkinson Disease ll: Pathophysiology
Alzheimer Disease l: Introduction
Neural Regulation
Parkinson's Disease: Overview

